Skip to main content
Clinical Trials/NCT02370914
NCT02370914
Completed
Not Applicable

Concussion Testing: A Novel Non-invasive Concussion Detection Device

Jan Medical, Inc.1 site in 1 country84 target enrollmentAugust 2011
ConditionsConcussion

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Concussion
Sponsor
Jan Medical, Inc.
Enrollment
84
Locations
1
Primary Endpoint
A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to establish and evaluate a distinctive signal for concussion.

Detailed Description

The purpose of this study is to establish a non-invasive objective measurement for the detection of concussions with the Jan Medical Device (JMD). The study will assess the ability of this device to demonstrate unique signals that correlate with concussions. The study will also test the athletes at baseline at rest and during exertion to determine if there is a difference in the signal from exertion alone. The JMD is a non-invasive band that is placed around the participants head. The JMD detects a unique pattern of signals based on displacement of the skull from changes in blood flow during individual heartbeats. The athletes will be tested longitudinally to assess to changes over time, in addition to changes after impact

Registry
clinicaltrials.gov
Start Date
August 2011
End Date
December 2011
Last Updated
3 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Junior Varsity and Varsity Players a local High School.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data

Time Frame: Individual assessments were made within 2 days of recording

Sensitivity (also called the true positive rate) measures the proportion of concussed participants that are correctly identified as such by utilizing the information within the Nautilus Neurowave data. Specificity (also called the true negative rate) measures the proportion of non-concussed participants that are correctly identified as such by utilizing the information within the Nautilus Neurowave data The information that is evaluated from within this data is recognized through the computation of two parameters, R1 and R2. Both R1 and R2 are measured by computing the frequency spectrum using an FFT of the Neurowave data and computing a ratio of the signal intensities at specific higher frequencies against specific lower frequencies within that spectrum. Based on this computation, the recorded data is evaluated as coming from a concussed participant if R1 \>= 1.0 and R2 \>= 0.66 and is considered non-concussed otherwise.

Study Sites (1)

Loading locations...

Similar Trials